基本信息
浏览量:0
职业迁徙
个人简介
Following a BSc (Hons) in Biomedical Sciences and MSc in Molecular Pathology and Toxicology, Suzanne achieved her PhD in Breast Cancer in Younger Women (2002) under the supervision of Profs Jacqui Shaw and Rosemary Walker at the University of Manchester.
Suzanne’s first appointment was as Investigator Scientist at the MRC Toxicology Unit moving to the Division of Reproductive Sciences at the University of Leicester. Investigating the molecular mechanisms by which oestradiol and the Selective Oestrogen Receptor Modulator tamoxifen exert their tissue specific effects by assessment of receptor involvement and agonist/antagonist behaviour, proliferative response and subsequent transcription of target genes.
Suzanne joined the University of Manchester in 2007 as a post-doctoral research associate in Dr John Burthem’s research group where she created a collection of IgM-secreting hetero-hybridomas derived from a range of clinical cases of Chronic Lymphocytic Leukaemia that had defined immunoglobulin gene rearrangement. This enabled the harvest of CLL-Ig in native IgM form for further investigation including tissue microarray to identify antigen.
In 2010, Suzanne joined Prof Vaskar Saha’s research group based at the Paterson Institute for Cancer Research. Here she developed a strong interest in the emerging field of extracellular vesicle (EV) research; characterising Leukaemic cell derived extracellular vesicles and investigating their potential role in intracellular communication within the bone marrow microenvironment and exploring how vesicle uptake might elicit phenotypic change. In 2015/16 Suzanne undertook a 50% secondment to support the Institute of Cancer Sciences Prof Sir Salvador Moncada as a project manager. Suzanne published 2 first author papers, contributed to 5 others and was lead applicant on an MRC Proximity to Discovery Relationship Incubator Award. In 2017 Suzanne was awarded a Recognising and Rewarding Exceptional Performance Award.
Continuing her interest in the potential of EVs in cancer-normal cell communication and as potential reservoirs of biomarkers for cancer early detection, Suzanne joined Dr Martin McCabe to investigate the potential role of EVs in paediatric brain tumours, particularly medulloblastoma. Presenting her research internationally, Suzanne secured funding from CRUK Early Detection Primer Award as lead applicant. Suzanne was promoted to Research Fellow in August 2019.
In March 2020 Suzanne was appointed as Lecturer and Programme Director for the new online UMW MSc Transformative Oncology.
Suzanne’s first appointment was as Investigator Scientist at the MRC Toxicology Unit moving to the Division of Reproductive Sciences at the University of Leicester. Investigating the molecular mechanisms by which oestradiol and the Selective Oestrogen Receptor Modulator tamoxifen exert their tissue specific effects by assessment of receptor involvement and agonist/antagonist behaviour, proliferative response and subsequent transcription of target genes.
Suzanne joined the University of Manchester in 2007 as a post-doctoral research associate in Dr John Burthem’s research group where she created a collection of IgM-secreting hetero-hybridomas derived from a range of clinical cases of Chronic Lymphocytic Leukaemia that had defined immunoglobulin gene rearrangement. This enabled the harvest of CLL-Ig in native IgM form for further investigation including tissue microarray to identify antigen.
In 2010, Suzanne joined Prof Vaskar Saha’s research group based at the Paterson Institute for Cancer Research. Here she developed a strong interest in the emerging field of extracellular vesicle (EV) research; characterising Leukaemic cell derived extracellular vesicles and investigating their potential role in intracellular communication within the bone marrow microenvironment and exploring how vesicle uptake might elicit phenotypic change. In 2015/16 Suzanne undertook a 50% secondment to support the Institute of Cancer Sciences Prof Sir Salvador Moncada as a project manager. Suzanne published 2 first author papers, contributed to 5 others and was lead applicant on an MRC Proximity to Discovery Relationship Incubator Award. In 2017 Suzanne was awarded a Recognising and Rewarding Exceptional Performance Award.
Continuing her interest in the potential of EVs in cancer-normal cell communication and as potential reservoirs of biomarkers for cancer early detection, Suzanne joined Dr Martin McCabe to investigate the potential role of EVs in paediatric brain tumours, particularly medulloblastoma. Presenting her research internationally, Suzanne secured funding from CRUK Early Detection Primer Award as lead applicant. Suzanne was promoted to Research Fellow in August 2019.
In March 2020 Suzanne was appointed as Lecturer and Programme Director for the new online UMW MSc Transformative Oncology.
研究兴趣
论文共 15 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Claire V Hutchinson, Shiva Natarajan,Suzanne M Johnson,Julie A Adams,Karen S Rees-Unwin,John Burthem
Experimental Hematology & Oncologyno. 1 (2014): 7-7
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn